Drugs that contain Carbidopa; Entacapone; Levodopa
1. Stalevo 100 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5446194 | ORION PHARMA | Pharmacologically active catechol derivatives |
Oct, 2013
(10 years ago) | |
| US6797732 | ORION PHARMA | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
| US6500867 | ORION PHARMA | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
Market Authorisation Date: 11 June, 2003
Treatment: Treatment of parkinson's disease
Dosage: TABLET;ORAL
How can I launch a generic of STALEVO 100 before it's drug patent expiration?
More Information on Dosage
STALEVO 100 family patents
2. Stalevo 125 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5446194 | ORION PHARMA | Pharmacologically active catechol derivatives |
Oct, 2013
(10 years ago) | |
| US6500867 | ORION PHARMA | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
| US6797732 | ORION PHARMA | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
Market Authorisation Date: 11 June, 2003
Treatment: Treatment of parkinson's disease
Dosage: TABLET;ORAL
How can I launch a generic of STALEVO 125 before it's drug patent expiration?
More Information on Dosage
STALEVO 125 family patents
3. Stalevo 150 patents
expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5446194 | ORION PHARMA | Pharmacologically active catechol derivatives |
Oct, 2013
(10 years ago) | |
| US6797732 | ORION PHARMA | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
| US6500867 | ORION PHARMA | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
Market Authorisation Date: 11 June, 2003
Treatment: Treatment of parkinson's disease
Dosage: TABLET;ORAL
How can I launch a generic of STALEVO 150 before it's drug patent expiration?
More Information on Dosage
STALEVO 150 family patents
4. Stalevo 200 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5446194 | ORION PHARMA | Pharmacologically active catechol derivatives |
Oct, 2013
(10 years ago) | |
| US6797732 | ORION PHARMA | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
| US6500867 | ORION PHARMA | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
Market Authorisation Date: 11 June, 2003
Treatment: Treatment of parkinson's disease
Dosage: TABLET;ORAL
How can I launch a generic of STALEVO 200 before it's drug patent expiration?
More Information on Dosage
STALEVO 200 family patents
5. Stalevo 50 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5446194 | ORION PHARMA | Pharmacologically active catechol derivatives |
Oct, 2013
(10 years ago) | |
| US6797732 | ORION PHARMA | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
| US6500867 | ORION PHARMA | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
Market Authorisation Date: 11 June, 2003
Treatment: Treatment of parkinson's disease
Dosage: TABLET;ORAL
How can I launch a generic of STALEVO 50 before it's drug patent expiration?
More Information on Dosage
STALEVO 50 family patents
6. Stalevo 75 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5446194 | ORION PHARMA | Pharmacologically active catechol derivatives |
Oct, 2013
(10 years ago) | |
| US6797732 | ORION PHARMA | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
| US6500867 | ORION PHARMA | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
Jun, 2020
(3 years ago) | |
Market Authorisation Date: 11 June, 2003
Treatment: Treatment of parkinson's disease
Dosage: TABLET;ORAL
How can I launch a generic of STALEVO 75 before it's drug patent expiration?
More Information on Dosage
STALEVO 75 family patents